HIV-1 Protease" Explored by Chemical Synthesis MANUEL BACA and STEPHEN B
Total Page:16
File Type:pdf, Size:1020Kb
Proc. Natl. Acad. Sci. USA Vol. 90, pp. 11638-11642, December 1993 Biochemistry Catalytic contribution of flap-substrate hydrogen bonds in "HIV-1 protease" explored by chemical synthesis MANUEL BACA AND STEPHEN B. H. KENT* The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA 92037 Communicated by Harry B. Gray, August 9, 1993 ABSTRACT An analogue of "HIV-1 protease" was de- the inhibitor. In crystal structures of both types of aspartic signed in which the ability to donate important water-mediated proteinases, hydrogen bonds are observed between the pro- hydrogen bonds to substrate was precisely and directly deleted. tein backbone near the tip of the flap(s) and the carbonyl Chemical ligation ofunprotected peptide segments was used to oxygens flanking the pseudoscissile bond of bound, sub- synthesize this "backbone-engineered" enzyme. The function- strate-based peptide inhibitor. These flap-substrate hydro- ally relevant amide -CONH- linkage between residues Gly49- gen bonds have been implicated in an out-of-plane distortion le50 in each flap of the enzyme was replaced by an isosteric of the scissile amide bond, thereby facilitating attack by a thioester -COS- bond. The backbone-engineered enzyme had nucleophilic water molecule (6-9). However, while the amide normal substrate specificity and affinity (Kn). However, the -NH- of peptide bonds near the tip of the single flap in pepsin-like proteinases donate hydrogen bonds directly to the catalytic activity (kct) was reduced -3000-fold compared to substrate (6, 10), the corresponding hydrogen bonds in the the native amide bond-containing enzyme. Inhibition by the HIV-1 protease are contributed one from each flap and reduced peptide bond substrate analogue MVT-101 was unaf- appear to be mediated by a specific, tetrahedrally coordi- fected compared with native enzyme. By contrast, the normally nated internal water molecule, water 301 (5), poised between tight-binding hydroxyethylamine inhibitor JG-365 bound to the flaps and the inhibitor (Fig. 1A). This water molecule the backbone-engineered enzyme with an -2500-fold reduc- (which is not the nucleophilic water) has been observed in all tion in affinity. The reduced catalytic activity of the -Gly49- HIV-1 protease enzyme-inhibitor cocrystal structures so far *(COS)-lles- backbone-engineered enzyme analogue provides reported (11). This raises the question, are the water- direct experimental evidence to support the suggestion that mediated hydrogen bonds from the flaps to substrate/ backbone hydrogen bonds from the enzyme flaps to the sub- inhibitor important to the enzyme activity of the HIV-1 strate are important for the catalytic function of the HIV-1 protease? protease. We sought to experimentally address the role of the hydrogen bonds between enzyme flaps and the substrate in The mature proteins packaged within virions of the human the mode of action of the HIV-1 protease. An enzyme immunodeficiency virus (HIV) are initially translated as the analogue was designed in which the protein backbone would large precursor polyproteins gag and gag-pol. The role ofthe lack the ability to donate the flap hydrogen bonds observed aspartic proteinase from HIV-1 ("HIV-1 protease") is to in the x-ray crystal structure (5, 7, 8). A sulfur atom specif- proteolytically process these translation products to give ically substitutes for an -NH- in a single peptide bond in the functional core proteins and the enzymes required for viral backbone of each flap (Fig. 1B). This could be done with replication (1). surgical precision using the chemical dovetailing approach In contrast to the single-chain nonviral aspartic proteinases (13), which creates a backbone analogue structure at the such as pepsin, the HIV-1 protease has been characterized as ligation site. This report describes the synthesis and enzy- a homodimeric molecule (2). The monomer of the HIV-1 matic properties ofa "backbone-engineered" analogue ofthe protease consists of 99 amino acid residues, and each mono- HIV-1 protease, in which the functionally relevant amide mer contributes one ofthe two conserved active-site aspartyl bond between residues Gly49 and 11e50 has been replaced by residues. X-ray crystallography has revealed the HIV-1 pro- a thioester linkage. tease to be structurally related to the larger two-domain pepsin-like aspartic proteinases (2-4). Despite the difference MATERIALS AND METHODS in quaternary structure, the similarity between the two types of aspartic proteinases is immediately obvious upon super- Bromomethylvaleric Acid. (2R,3S)-2-Bromo-3-methylva- position of the molecular structures (2). leric acid (BrMV) was synthesized from D-allo-isoleucine An important structural feature of the aspartic proteinases [i.e., (2R,3S)-2-amino-3-methylvaleric acid] by in situ forma- is the 3-hairpin region known as the "flap". The flap is a tion of the diazonium salt in the presence ofbromide ion (14, mobile surface feature, characterized by high thermal factors 15). The crude reaction product was purified by reverse- in the crystal structures of the free enzyme (4). The ho- phase HPLC, and the identity of this product was confirmed modimeric HIV-1 protease molecule possesses two flaps, in by 'H NMR. The stereochemistry and chiral purity of this contrast to the single flap of the pepsin-like proteinases (2). compound was verified by synthesis of its diastereomer Upon binding inhibitor (and presumably substrate), the (2S,3S)-2-bromo-3-methylvaleric acid from L-isoleucine and flap(s) undergoes movement to interact with and lock the comparison oftheir 'H NMR spectra. Within the limits of 'H substrate into the active site, simultaneously desolvating the NMR sensitivity, BrMV was chirally pure. enzyme-bound ligand (4, 5). Peptide Synthesis. HIV-1 protease (SF2 strain) segments Potentially the most significant and intriguing difference 1-49 and 51-99 were synthesized as described elsewhere (13, between the HIV-1 protease and nonviral aspartic protein- ases is in the mode of interaction of the tip of the flap(s) with Abbreviations: HIV, human immunodeficiency virus; BrMV, (2R,3S)-2-bromo-3-methylvaleric acid; Boc, t-butoxycarbonyl; Aba, L-a-amino-n-butyric acid. The publication costs ofthis article were defrayed in part by page charge *To whom reprint requests should be addressed at: Mail Drop payment. This article must therefore be hereby marked "advertisement" CVN-6, The Scripps Research Institute, 10666 North Torrey Pines in accordance with 18 U.S.C. §1734 solely to indicate this fact. Road, La Jolla, CA 92037. 11638 Downloaded by guest on September 24, 2021 Biochemistry: Baca and Kent Proc. Natl. Acad. Sci. USA 90 (1993) 11639 A B FIG. 1. Hydrogen-bonding interactions be- tween the flap regions of the HIV-1 protease and a substrate-based inhibitor. (A) Hydrogen bonds from the enzyme backbone Ile50 -NH- in each flap to the inhibitor P2 and P1l carbonyls [notation of 11 \le50 li e5O' Schecter and Berger (12)] on either side of the isostere of the substrate scissile bond. The hydro- IS gen bonds are mediated by a specific, tetrahedrally coordinated water (water 301) observed in all HIV-1 protease-inhibitor complexes. The data were taken from the x-ray crystal structure of synthetic HIV-1 protease bound to the reduced isostere hexapeptide inhibitor MVT-101 (5). (B) Design of a backbone- engineered HIV-1 protease. This shows a hypothet- ical structure in which the single pertinent -CONH- in each flap has been converted to a -COS-, thus removing the ability to donate a hydrogen bond. Water 301 is modeled as hydrogen bonded only to the substrate-based inhibitor. [Note that in HIV-1 Asp25' Asp25 Asp25' Asp25 protease the scissile peptide bond is attacked by a water molecule (not water 301) located between the Asp25 and Asp25' side chains.] 16). The 51-99 segment contained L-a-amino-n-butyric acid extinction coefficient of 25,000 M-lcm-1 (20). Typically, (Aba) as an isosteric replacement for cysteine at positions 67 0.35 mg of folded enzyme analogue was obtained, reflecting and 95 (2). BrMV was coupled as the preformed symmetric a yield of 4.5% based on the starting peptide segments. anhydride (17) to the (51-99)HIV-1 protease segment, after Folded enzyme was stored in dialysis buffer at 4°C, and under first removing the His(dinitrophenyl) and Na-t-butoxycar- these conditions, no significant autolytic or chemical degra- bonyl (Boc) protecting groups from the resin-bound peptide dation ofthe enzyme was observed after a period of4 weeks. (16). Removal of remaining side chain protecting groups and The molecular mass of folded [(COS)49-50]HIV-1 protease from the resin was effected by treatment with dimer (hereafter referred to as backbone-engineered HIV-1 cleavage PR) was investigated by gel filtration using a Pharmacia hydrogen fluoride (16) to yield BrMV (51-99)HIV-1 protease. Superdex 75 column, running at 0.5 ml/min with 100 mM The peptide segment 1-49 was synthesized on a Boc-Gly-S- NaOAc/0.5 M NaCl, pH 5.3, as the mobile phase. The CH(phenyl)phenoxyacetamidomethyl resin (18). Cleavage concentration of enzyme as loaded onto the column was 0.4 and deprotection to yield the desired (1-49)-aCOSH segment ,uM, and protein peaks were detected by fluorescence at 335 was similarly performed after prior removal of the Na-Boc nm (excitation 280 nm). The observed molecular mass of group. backbone-engineered HIV-1 PR was determined from a plot Each peptide segment was purified by reverse-phase of log(molar mass) versus retention time, calibrated by coin- HPLC using linear gradients of acetonitrile in 0.1% aqueous jection of reference proteins. trifluoroacetic acid. Fractions collected were combined Enzymatic Properties. Comparison of the substrate speci- based on analysis by isocratic HPLC and ion-spray MS.